AKCEA THERAPEUTICS INC's ticker is and the CUSIP is 00972L907. A total of 4 filers reported holding AKCEA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $346,000 | -18.6% | 22,500 | +22.3% | 0.00% | – |
| Q2 2019 | $425,000 | -92.3% | 18,400 | -90.6% | 0.00% | -100.0% |
| Q1 2019 | $5,524,000 | -5.3% | 195,000 | +0.8% | 0.00% | 0.0% |
| Q4 2018 | $5,832,000 | +270.1% | 193,500 | +330.0% | 0.00% | – |
| Q3 2018 | $1,576,000 | +23.1% | 45,000 | -16.7% | 0.00% | – |
| Q2 2018 | $1,280,000 | – | 54,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 900 | $14,000 | 0.00% |
| SIMPLEX TRADING, LLC | 37 | $56,000 | 0.00% |
| JPMORGAN CHASE & CO | 22,500 | $346,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |